| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.53▲ | 7.51▲ | 7.51▲ | 7.41▲ | 6.79▲ |
| MA10 | 7.48▲ | 7.28▲ | 7.25▲ | 7.08▲ | 4.82▲ |
| MA20 | 7.22▲ | 7.24▲ | 7.16▲ | 6.52▲ | 2.59▲ |
| MA50 | 6.80▲ | 6.42▲ | 6.32▲ | 4.09▲ | 1.40▲ |
| MA100 | 6.35▲ | 6.47▲ | 6.26▲ | 2.22▲ | 1.19▲ |
| MA200 | 6.41▲ | 4.49▲ | 3.61▲ | 1.41▲ | 1.76▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.017▲ | 0.026▲ | -0.040▼ | 0.695▲ |
| RSI | 59.606▲ | 61.835▲ | 61.948▲ | 63.309▲ | 80.009▲ |
| STOCH | 70.959 | 84.261▲ | 88.608▲ | 84.742▲ | 88.977▲ |
| WILL %R | -3.627▲ | -3.627▲ | -5.102▲ | -11.748▲ | -3.701▲ |
| CCI | 74.729 | 94.068 | 85.097 | 75.736 | 83.572 |
|
Thursday, August 14, 2025 04:00 PM
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) announced second-quarter 2025 results and reported key advancements in its upliFT-D clinical trial, including completion of dosing in the second ...
|
|
Thursday, August 14, 2025 06:27 AM
Find the latest institutional holdings data for Passage Bio, Inc. Common Stock (PASG) including shareholders, ownership summaries, and holding activities at Nasdaq.com.
|
|
Thursday, August 14, 2025 06:25 AM
Canaccord lowered the firm’s price target on Passage Bio (PASG) to $67 from $260 and keeps a Buy rating on the shares. The firm decreased its peak ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/08/25 | 7.70 | 7.70 | 7.24 | 7.475 | 16,345 |
| 22/08/25 | 7.53 | 7.6505 | 7.13 | 7.54 | 47,545 |
| 21/08/25 | 7.70 | 7.70 | 7.3029 | 7.3999 | 9,806 |
| 20/08/25 | 6.73 | 7.75 | 6.73 | 7.69 | 37,319 |
| 19/08/25 | 7.2812 | 7.39 | 6.6507 | 6.925 | 25,628 |
| 18/08/25 | 7.10 | 7.4968 | 6.80 | 7.22 | 57,454 |
| 15/08/25 | 7.47 | 7.65 | 6.79 | 6.95 | 61,742 |
| 14/08/25 | 6.50 | 7.65 | 6.50 | 7.59 | 75,249 |
| 13/08/25 | 5.52 | 6.73 | 5.52 | 6.38 | 36,125 |
| 12/08/25 | 5.75 | 5.954 | 5.5099 | 5.61 | 40,007 |
|
|
||||
|
|
||||
|
|